joshua bilenker loxo oncology inc profile  biography  bloomberg feedback joshua josh bilenker presidentceofounder loxo oncology inc career history operating partner aisling capital llc present presidentceofounder loxo oncology inc present partner aisling capital llc  principal aisling capital llc  associate aisling capital llc  medical ofcroncology drug usfood  drug administration  show more website wwwloxooncologycom corporate information address  tresser blvd th floor stamford ct  united states phone  fax  web url wwwloxooncologycom from the web personal information education johns hopkins university school of medicinethe md  princeton university bachelors degree english  memberships board memberships bioenterprise corp board member present nccn foundation board member present loxo oncology inc board member present viewray inc board member present t biosystems inc board member  roka bioscience inc board member  lensar inc board member former bioenterprise corp board member former show more other memberships nccn foundation board member sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data josh bilenker md  aisling capital toggle navigation team aisling capital team aisling capital is led by a group of investment professionals with diverse backgrounds in industry science and finance the team’s complementary backgrounds give aisling capital unique perspective on the key players events and forces shaping the life science industry and allow the fund to identify investment opportunities in working with our portfolio companies the principals of aisling capital seek to provide the financing relationships and guidance needed to build highly successful companies steven a elms managing partner steven a elms mr elms joined aisling in july of  and currently serves as one of the managing partners previously he was a principal in the life sciences investment banking group of hq during his five years at hq mr elms was involved in over  financing and ma transactions helping clients raise in excess of  billion in capital prior to hq mr elms traded mortgagebacked securities at donaldson lufkin  jenrette his previous healthcare sector experience includes over two years as a pharmaceutical sales representative for marion laboratories and two years as a consultant for the wilkerson group mr elms currently serves as a director of adma biologics earlens and loxo oncology previously he served as a director of advion biosciences ambit biosciences archimica cooperatief avera pharmaceuticals bioenvision cenerx biopharma cidara therapeutics lensar nextwave pharmaceuticals novazyme pharmaceuticals pernix therapeutics scerene healthcare and tria beauty and was chairman of the board of adams respiratory therapeutics map pharmaceuticals and oculex pharmaceuticals mr elms received his mba from the kellogg graduate school of management at northwestern university and his ba in human biology from stanford university andrew schiff md managing partner andrew schiff md dr schiff joined aisling in september of  and currently serves as one of the managing partners prior to aisling capital dr schiff practiced internal medicine for six years at the new york presbyterian hospital where he maintains his position as a clinical assistant professor of medicine dr schiff currently serves as a director of armgo pharma powervision and zeltiq aesthetics and as a board observer of zavante therapeutics prior board service includes adams respiratory therapeutics agile therapeutics arginox pharmaceuticals barrier therapeutics bioenvision cardiokine cempra pharmaceuticals miramar labs myogen skinmedica sirion therapeutics transenterix and quintiles board observer he is a longtime supporter and board member of the visiting nurse service of new york dr schiff received his md from cornell university medical college his mba from columbia university and his bs with honors in neuroscience from brown university dov a goldstein md managing partner dov a goldstein md dr goldstein joined aisling in  and currently serves as one of the managing partners prior to joining aisling dr goldstein served as executive vice president and chief financial officer of vicuron pharmaceuticals for five years up until its acquisition by pfizer while at vicuron pharmaceuticals he raised over  million in an ipo pipe followon and block trade transactions he led the valuation and finance due diligence for the merger with biosearch italia nuovo mercato biomi the first us and italian publictopublic company merger he also ran the investor relations and press relations efforts for the company prior to vicuron dr goldstein was director of venture analysis at healthcare ventures he also completed an internship in the department of medicine at columbiapresbyterian hospital dr goldstein currently serves as a director of adma biologics cempra pharmaceuticals and esperion therapeutics previously he served as a director of durata therapeutics acquired by actavis loxo oncology also served as chief financial officer and topaz pharmaceuticals acquired by sanofi and on other private company boards dr goldstein received his md from yale school of medicine he received his mba from columbia business school and his bs with honors from stanford university dennis j purcell founder and senior advisor dennis j purcell mr purcell is the original founder of aisling capital llc and currently serves as a senior advisor to aisling previously he served as the senior managing partner prior to aisling capital mr purcell served as managing director of the life sciences investment banking group at chase hq formerly hambrecht  quist “hq” for over five years while at hq he was directly involved with over two hundred completed transactions and supervised over  billion of financing and advisory assignments in the pharmaceutical biotechnology and medical products industries during his tenure bioworld and other industry publications cited hq as the leading underwriter of life sciences securities prior to joining hq mr purcell was a managing director in the healthcare group at painewebber inc mr purcell is a frequent commentator on the industry and has been honored in the “biotech hall of fame” by genetic engineering news named to the biotechnology allstars list by forbes asap honored as one of the top  irishamerican businessmen and cited as one of the top  contributors to the biotechnology industry mr purcell has served as a director of aton pharma bridge pharmaceuticals cengent therapeutics dynova laboratories paratek pharmaceuticals valentis and xanodyne pharmaceuticals he has served as a member of the advisory council at harvard medical school the board of directors of the biotechnology industry association as well as the new york biotechnology association the irvington institute and on the board of lek consulting he currently sits on the board of real endpoints summus global inc life science leader magazine –editorial advisory board ny bio association and is a member of the university of delaware investment visiting committee member mr purcell received his mba from harvard university and his bs in accounting from the university of delaware eric aguiar md partner eric aguiar md dr aguiar joined aisling in  prior to joining aisling dr aguiar was a partner at thomas mcnerney and partners a  million health care focused venture capital and growth equity fund from  dr aguiar was a managing director of healthcare ventures a health care venture capital fund from  he currently sits on the boards of biohaven and invitae corporation his prior board seats have included amarin oriel therapeutics inc acquired by novartis ag virdante pharmaceuticals inc acquired by momenta pharmaceuticals cardiokine inc acquired by cornerstone therapeutics skinmedica inc acquired by allergan vaxinate inc metaphore and d pharmaceuticals acquired by johnson  johnson he was ceo of genovo inc acquired by targeted genetics a biopharmaceutical company that specialized in gene delivery and gene regulation he was also executive director of theratech inc acquired by watson pharmaceuticals he was a vice president and managing director of philadelphia ventures from  to  dr aguiar is a member of the board of overseers of the tufts school of medicine and a member of the council on foreign relations he received his medical degree with honors from harvard medical school he graduated with honors from cornell university as a college scholar he was also a luce fellow and is a chartered financial analyst aftab r kherani md partner aftab r kherani md dr kherani joined aisling in  and currently serves as a partner previously dr kherani was an engagement manager for two years at mckinsey  company where he was a member of the pharmaceutical medical product and private equity practices prior to mckinsey dr kherani was a chief resident in surgery at duke university medical center where he completed his residency in general surgery he also completed a twoyear postdoctoral research fellowship investigating treatments for heart failure and arrhythmia at columbia university college of physicians  surgeons while at columbia he additionally served as an organ procurement fellow as part of the cardiothoracic transplantation team of new york presbyterian hospital dr kherani currently serves as a director of spirox and transenterix and as a board observer at armgo pharma earlens loxo oncology syros pharmaceuticals and t biosystems dr kherani received his md from duke university school of medicine where he was a howard hughes medical institute research fellowship recipient he also received his bs in biology and ab in economics from duke both magna cum laude graduating phi beta kappa stacey d seltzer partner stacey d seltzer ms seltzer joined aisling in  and currently serves as a partner previously ms seltzer was at scheringplough where she held roles in business development marketing and sales most recently serving as the us scheringplough brand lead for zetia while in business development ms seltzer was involved in the structuring and negotiation of several deals with an aggregate value in the billions ranging from inlicensing deals to broad development and commercialization alliances prior to scheringplough ms seltzer was the director of business development for akceli a biotechnology company developing cellbased microarrays ms seltzer began her career as a management consultant for mckinsey  company ms seltzer serves as a director of aimmune therapeutics miramar labs and promentis pharmaceuticals and as a board observer of prolacta bioscience previously she served as a board observer for agile therapeutics durata therapeutics acquired by actavis and zeltiq aesthetics she also acted as the aisling representative for its investment in precision dermatology acquired by valeant and was closely involved in aisling’s investments in cytos dermira and powervision ms seltzer received her mba from the wharton school at the university of pennsylvania where she was a palmer scholar she received her ms and bs from yale university awarded cum laude in molecular biophysics and biochemistry josh bilenker md operating partner josh bilenker md dr bilenker joined aisling in  and currently serves as an operating partner he is president and chief executive officer of loxo oncology an aisling capital iii portfolio company prior to aisling dr bilenker served as a medical officer in the office of oncology drug products at the us food and drug administration for two years while at the fda he conducted clinical reviews of indstage and licensed biologic oncology products prior to joining the fda dr bilenker trained at the university of pennsylvania in internal medicine and medical oncology earning board certification in these specialties dr bilenker currently serves as a director of loxo oncology and viewray previously he served as a director of lensar roka bioscience and t biosystems and as a board observer at aragon pharmaceuticals he is also a board member of the nccn foundation and of bioenterprise dr bilenker received his md from the johns hopkins school of medicine he received his ab from princeton awarded summa cum laude in english scott braunstein md operating partner scott braunstein md dr braunstein serves as an operating partner at aisling capital he is senior vice president strategy and corporate development at pacira pharmaceuticals dr braunstein spent  years as a healthcare analyst and portfolio manager at jp morgan asset management where he invested in and conducted diligence on a wide variety of pharmaceutical products and product candidates he reviewed pharmaceutical company strategies business models and management teams and provided stock recommendations for the jp morgan asset equity group dr braunstein serves as a director of esperion therapeutics stat medical and the cornell alumni association for the college of agriculture and life sciences dr braunstein received his md from the albert einstein college of medicine and completed his residency in internal medicine at cornell universitynew york hospital he received his bs from cornell university ayman sabi operating partner ayman sabi mr sabi is an independent consultant serving as an operating partner at aisling capital he is the founder of sabi medical group bv and a seasoned entrepreneur with almost  years of fiscal strategic and operational leadership mr sabi founded and led sabi ventures and sabi trading and contracting inc which focused on international trade retail and real estate formerly mr sabi was ceo andor director of white house  black market inc acquired by chico’s inc in  roadhouse grill inc ipo  nasdaq new global llc shopping centers sold  and national retail group inc mr sabi has a bs from north carolina state university wonpyo yun analyst wonpyo yun mr yun joined aisling in july  and serves as an analyst previously mr yun was an analyst in the healthcare investment banking group at credit suisse in new york mr yun holds an ab in molecular biology awarded magna cum laude from princeton university where he also received a certificate in finance robert j wenzel chief financial officer robert j wenzel mr wenzel joined aisling in june  and has served as chief financial officer since april  having previously served as controller for nine years for  years prior to joining aisling he was vice president at lazard alternative investments “lazard” where he supervised the financial reporting of several domestic and offshore private equity funds prior to joining lazard mr wenzel began his career at eisner  lubin llp a midsize public accounting firm where he performed audits and prepared tax reports for a diverse clientele attaining the role of senior accountant mr wenzel received his bba in accounting from baruch college in  and holds his certified public accountant license in the state of new york he is also a member of the american institute of certified public accountants and the new york state society of certified public accountants hannah wieder controller hannah wieder ms wieder joined aisling in march  and serves as the controller prior to joining aisling she was an audit manager in the wealth  asset management practice at ernst  young where her focus was on private equity ms wieder also spent six years in the financial services group at cohnreznick a midsize public accounting firm where she attained the role of audit manager and directed the annual audits of various clients within the financial services industry including private equity funds funds of funds and management companies ms wieder received her ms in accountancy from the zicklin school of business at baruch college and received her bs in business management and finance awarded magna cum laude from brooklyn college she is a certified public accountant licensed in the state of new york and is a member of the american institute of certified public accountants and the new york state society of certified public accountants jan hoerrner director of investor relations and marketing jan hoerrner ms hoerrner joined aisling in october of  and serves as the director of investor relations and marketing at aisling capital in this role ms hoerrner manages relationships with over eighty limited partners and is a key contributor in aisling’s fundraising and marketing efforts previously ms hoerrner was with hq a leading underwriter and strategic advisor to the biotechnology industry during her five years at hq ms hoerrner was responsible for coordinating their healthcare conferences and also served as administrative manager for the new york office ms hoerrner received her bs in business administration from bryant university loxo joshua h bilenker insider trades for loxo oncology inc bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close loxo oncology inc nasdaq loxo go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus loxo oncology inc after hours  quotes are delayed by  min jul    pm loxo quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual joshua h bilenker dr joshua h bilenker md is president chief executive officer cfo  director at loxo oncology inc independent director at t biosystems inc and operating partner at aisling capital llc he is on the board of directors at loxo oncology inc roka bioscience inc t biosystems inc lensar inc viewray inc and bioenterprise inc prior to joining aisling in  dr bilenker served as a medical officer in the office of oncology drug products at the us food and drug administration for two years prior to that he trained at the university of pennsylvania in internal medicine and medical oncology earning board certification in these specialties previously he served as a board observer at aragon pharmaceuticals he is also a board member of the nccn foundation and of bioenterprise dr bilenker received his md from the johns hopkins school of medicine he received his ab from princeton awarded summa cum laude in english transactions date shares transaction value copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr joshua h bilenker president chief executive officer  director ms sara slifka executive directorbusiness operations ms jennifer burstein vice presidentfinance dr nisha nanda vice presidentstrategy development dr aftab r kherani director dr lori anne kunkel director dr keith t flaherty director mr jacob s van naarden chief business officer  headinvestor relations dr steven d harr independent director mr alan fuhrman independent director mr tim m mayleben independent director mr avi z naider independent director mr steven arnote elms independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pscaramucci on washington back stabbers ‘i’m more of a frontstabbing person’ pfacebook keeps warning about growth but growth doesn’t stop pfacebook heads toward  billion market cap after earnings pfoxconn pledges to build  billion stateoftheart electronics plant in wisconsin pgraham says trump is showing weakness in unilateral public spat with sessions pfacebook hits  billion users earnings beat boosts stock live blog recap pnew rules for ftse russell index provider to exclude snap others from benchmarks pthe nintendo switch’s sellout launch in many charts p coworkers you should avoid like the plague in meetings pcommunity health systems shares fall after profit warning pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  joshua h bilenker md executive profile  biography  bloomberg july    pm et biotechnology company overview of loxo oncology inc snapshotpeople  overviewboard memberscommittees executive profile joshua h bilenker mdfounder chief executive officer president and director loxo oncology incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background dr joshua h bilenker also known as josh md serves as an operating partner at aisling capital llc since november  dr bilenker has been the chief executive officer and president at loxo oncology inc since june  which he founded in may  he joined aisling capital llc in april  he previously served as a principal at the firm dr bilenker served as the chief financial officer and principal accounting officer at loxo oncology inc prior to aisling  capital llc he served as a medical officer in the office of oncology drug products at the united states food and drug administration from august  to april  while at the fda dr bilenker conducted clinical reviews of indstage and licensed biologic oncology products he has been a director of nccn foundation at national comprehensive cancer network since august  he has been a director at loxo oncology inc since june  he serves as a director of seachaid pharmaceuticals inc he served as a director of t biosystems inc from august   to january   he served as a director of bioenterprise corporation until february   dr bilenker served as a director of viewray inc since january  until june   and served as its independent director since january  to october   he served as a director of roka bioscience inc from december  to march  dr bilenker also served as a director of lensar inc he served as a board observer of aragon pharmaceuticals dr bilenker has extensive service as a director or officer of and as an investor in other healthcare companies he trained at the university of pennsylvania in internal medicine and medical oncology earning board certification in these specialties he received an md from the johns hopkins school of medicine he holds an ab in english awarded summa cum laude from princeton universityread full background corporate headquarters  tresser boulevardstamford connecticut united statesphone fax  board members memberships directorlensar incdirectorseachaid pharmaceuticals incpresentfounder chief executive officer president and directorloxo oncology inc education ba princeton universitymd johns hopkins school of medicine other affiliations bioenterprise corporationaisling capital llcprinceton universityjohns hopkins school of medicinenational comprehensive cancer network incviewray inct biosystems inclensar incroka bioscience incseachaid pharmaceuticals inc annual compensation salarytotal annual compensation stocks options exercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact loxo oncology inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close   joshua bilenker  loxo oncology inc  zoominfocom joshua h bilenker md  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in joshua h bilenker md dir president and chief executive officer at loxo oncology inc view full profile are you joshua h bilenker md claim your profile   sign up for equilar atlas and view joshua h bilenker mds full profile with equilar atlas you can identify corporate executives in joshua h bilenker mds network and community follow changes in joshua h bilenker mds employment and moneyinmotion connect with joshua h bilenker md through your network of contacts joshua h bilenker mds executive work history current dir president and chief executive officer loxo oncology inc board member viewray inc past to view joshua h bilenker mds complete executive work history sign up now age      joshua h bilenker mds biography dr joshua h bilenker founder of loxo oncology has served as president and chief executive officer since june  and as a member of our board of directors since june  since november  dr bilenker has served as an operating partner at aisling capital llc or aisling capital a private equity firm where he was a partner from january  to october  and previously served as a principal from october  to december  and an associate from april  to september  dr bilenker is on the board of directors of viewray inc he also serves on the nonprofit board of the nccn foundation from  to  dr bilenker serv  read more dr joshua h bilenker founder of loxo oncology has served as president and chief executive officer since june  and as a member of our board of directors since june  since november  dr bilenker has served as an operating partner at aisling capital llc or aisling capital a private equity firm where he was a partner from january  to october  and previously served as a principal from october  to december  and an associate from april  to september  dr bilenker is on the board of directors of viewray inc he also serves on the nonprofit board of the nccn foundation from  to  dr bilenker served as a medical officer at the fda in the office of oncology dr bilenker trained at the university of pennsylvania in internal medicine and medical oncology earning board certification in these specialties he received his md from the johns hopkins school of medicine and his ab degree in english from princeton university we believe that dr bilenker should serve on our board of directors due to his thorough knowledge of our company and his experience in finance and medicine source loxo oncology inc on    sign up for equilar atlas and view joshua h bilenker mds full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like joshua h bilenker md more specifically youll be able to identify corporate executives in joshua h bilenker mds network and community follow changes in joshua h bilenker mds employment and moneyinmotion connect with joshua h bilenker md through your network of conections view full profile   search for over  executive profiles bio example joshua h bilenker md joshua h bilenker mds connections  sign up now to view joshua h bilenker mds  connections » david p harding chief commercial officer t biosystems inc john w cumming former president and chief executive officer hologic inc keith t flaherty board member loxo oncology inc robert s langer board member dnib unwind paul g thomas chairman of the board roka bioscience inc david b aronoff former board member t biosystems inc timothy m mayleben dir president and chief executive officer esperion therapeutics inc mark s gold board member axogen inc michael j cima former board member t biosystems inc david b elsbree former board member t biosystems inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company carl g annessa evp and coo hornbeck offshore services inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   josh bilenker chief executive officer loxo oncology timesjavascript is disabled market profiles login sign up login sign up   edit person josh bilenker chief executive officer at loxo oncology location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop josh bilenker chief executive officer at loxo oncology location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop dr bilenker joined aisling in  and currently serves as an operating partner he is president and chief executive officer of loxo oncology an aisling capital iii portfolio company prior to aisling dr bilenker served as a medical officer in the office of oncology drug products at the us food and drug administration for two years while at the fda he conducted clinical reviews of indstage and licensed biologic oncology products prior to joining the fda dr bilenker trained at the university of pennsylvania in internal medicine and medical oncology earning board certification in these specialties dr bilenker currently serves as a director of lensar loxo oncology roka bioscience t biosystems and viewray previously he served as a board observer at aragon pharmaceuticals he is also a board member of the nccn foundation and of bioenterprise dr bilenker received his md from the johns hopkins school of medicine he received his ab from princeton awarded summa cum laude in english  companies in career na related markets  colleagues na related investments alias na industry rd in biotech environmental and various industries no marketing product yet tags oncology venture capital drug development corporate finance fda drug testing topics of influence na na careers achievements investments related people edit view all josh bilenkercareer  jul loxo oncology chief executive officer jan aisling capital partner viewray board member  to dec aisling capital principal  to  aisling capital associate  to  fda medical officer competencies edit view all josh bilenkereducation   the johns hopkins university school of medicine  princeton university english edit josh bilenkerachievements and recognitions add milestone no milestones has been recorded for josh bilenker edit josh bilenkerlinks add link no links has been recorded for josh bilenker josh bilenkerinvestmentsacquisitions no investments has been recorded for josh bilenker josh bilenkerinvestments representing others no investment reps has been recorded for josh bilenker josh bilenkerrelated people colleagues at loxo oncology jennifer low cmo executive vice president of research  development jul nisha nanda vp development feb sara slifka sr director operations dec joshua h bilenker chief executive officer jul view all peers  peter van vlasselaer president and ceo of arresto biosciences steve delity ceo of rapid micro biosystems tim herbert chief executive officer of inspire medical systems carr brendel chief executive officer of jenavalve technology david j drachman chief executive officer of jenavalve technology hugh griffith ceo of alida capital international view all josh bilenkerrecommended market profiles healthcare venture deals    employees  companies dr joshua bilenker md  stamford ct  hematology  healthgradescom healthgradesdr joshua bilenker mdlogin menusearch doctors hospitals specialties or proceduresclosehealthgradessearchsearchnearsearchdr joshua bilenker mdsavehematology  male leave a reviewbe the first to review this doctor landmark sq stamford ct  get directions  suggest an editdr joshua bilenker md is a hematology doctor who practices in stamford ct he is  years old and has been practicing for  yearsadvertisement learn about this doctordr bilenkers experienceexperiencematchexperience matchsee how dr bilenkers experience matches your preferencesspecialtiesfor the best healthcare for your needs choose a doctor who specializes in your medical conditionconditions treatedcheck to see that this provider treats your medical conditionprocedures performedcheck to see that this provider performs the procedure that you needbackground checkcheck to see if your provider has any malpractices board actions or sanctionseducationlearn more about where this provider went to medical school residency and morelanguages spokencheck to see what languages this provider andor staff speakmemberships  professional affiliationsview memberships and affiliations associated with this provideroverall patient satisfactionhave you recently visited dr bilenker fill out a survey to help millions of people around the nation find the right doctortake surveysee all  hematology specialists in stamford ct dr mark heaney mdhematologydr richard frank mdhematologydr anne angevine mdhematologydr richard zelkowitz mdhematologydr salvatore del prete mdhematologydr anthony provenzano mdhematologyview morevisiting dr bilenker landmark sqstamford ct  get directionsdr bilenkers reviewshelp millions of people find the right doctor share your experience todaybe the first to leave a revieware you dr bilenkermake it easy for patients to share their feedback also manage your personalized profileget started todaycompare dr bilenkercompare this doctorview other doctors with similar experience to find the right doctor for youdr mark heaney mdhematology palmer avebronxville ny patient satisfactiondistance miles awaydr richard frank mdhematology stevens stnorwalk ct patient satisfactiondistance miles awaydr anne angevine mdhematology hospital plazastamford ct patient satisfactiondistance miles awaydr richard zelkowitz mdhematology maple avegreenwich ct patient satisfactiondistance miles awaydr salvatore del prete mdhematology hospital plazastamford ct patient satisfactiondistance miles awaydr anthony provenzano mdhematology pondfield rd w ste bronxville ny patient satisfactiondistance miles awaydr michael garrison mdhematology old country rd ste mineola ny patient satisfactiondistance miles awaydr alexander hindenburg mdhematology old country rd ste mineola ny patient satisfactiondistance miles awaydr eduardo saponara mdhematology  oncology pondfield rd lowr levelbronxville ny patient satisfactiondistance miles awaydr jeffrey schneider mdhematology old country rd ste mineola ny patient satisfactiondistance miles awayview all  matchessee all hematologists in stamford ct×dr bilenkers experience matches your search based on the following criteria based on total number of patients treated over the last  months specializes in hematology no board certification on record with healthgrades no malpractice claims found no sanctions found no board actions found×background check  malpractice claimsno malpractice history found for connecticutwhat is medical malpracticewhat is medical malpracticemedical malpractice is issued when negligence by a doctor causes injury to a patient for example a doctor may improperly diagnose treat or medicate outside the standard of medical care the three types of malpractice are a settlement an arbitration award or a judgmentif my doctor has malpractice history does that mean he or she is a poorquality doctorif your doctor has a malpractice claim evaluate the information and determine if the action could potentially impact the quality of care you receive claim settlements and arbitration awards may occur for a variety of reasons which should not necessarily reflect negatively on the doctors professional competence or conductyou may want to use this information to start a discussion with the doctor about his or her history and specific ability to provide healthcare for youhow far back does healthgrades malpractice history gohealthgrades reports details of a doctor’s malpractice history when the doctor has at least one closed medical malpractice claim within the last five years even if he or she no longer practices in that statefor which states does healthgrades collect malpractice historyhealthgrades collects malpractice information from california colorado connecticut florida georgia illinois massachusetts nevada new jersey new york north carolina oregon tennessee texas vermont virginia and west virginia if your doctor has a malpractice claim evaluate the information and determine if the action could potentially impact your quality of care sometimes multiple states report the same claim if a provider practices in a state where data is unavailable please reach out to your local state legislature to help make this data publicly availablesanctionsno sanctions history found for the years that healthgrades collects datawhat is a sanction or disciplinary actionwhat is a sanction or disciplinary actiona sanction also known as a disciplinary action is an action taken to punish or restrict a doctor who has demonstrated professional misconduct sanctions may be imposed by a state medical board professional medical licensing organization or the us department of health and human servicesif my doctor has sanction history does that mean he or she is a poorquality doctorif a doctor has a sanction it does not necessarily mean that he or she is a poorquality doctor some sanctions are not related to medical care and involve a doctor’s finances or administrative activities before you make any choices about changing your doctor we recommend that you evaluate the doctor’s sanction information and determine how severe or relevant you think the sanction cause and action werehow far back does healthgrades sanction history gohealthgrades reports state and federal sanctions from the previous five years except when a doctors license has been revoked or surrendered healthgrades displays all actions for doctors whose licenses have been revoked or surrenderedfor which states does healthgrades collect sanction historyhealthgrades collects sanction history from all  us states physicians with a disciplinary action in one state may move to another state where they have a clean record since healthgrades painstakingly compiles disciplinary action information from all  states healthgrades website will show if a physician has a disciplinary action in more than one stateboard actionsno board actions found for the years that healthgrades collects datawhat are board actionswhat are board actionsboard actions are nondisciplinary actions imposed upon a doctor based on a complaint investigation a patient or medical colleague may file a complaint with that state medical board or professional licensing organization which then investigates the complaint board actions are intended to ensure that a doctor is able to perform safe medical and health care taskstypes of nondisciplinary actions include an advisory letter a corrective action agreement a limitation or restriction on the medical or healthcare tasks a doctor can perform or a voluntary agreement by the doctor not to practice a board action can also include a termination of a corrective action agreement or voluntary agreement which allows the doctor to return to full practiceif my doctor has a board action does that mean he or she is a poorquality doctorif a doctor has a board action it means he or she has had a nondisciplinary action imposed upon him or her it does not necessarily mean that he or she is a poor quality doctor before you make any choices about changing your doctor evaluate the doctors board action information and determine how severe or relevant you think the cause and action werehow far back does healthgrades nondisciplinary board action history gohealthgrades reports nondisciplinary board action history from for the previous five years except when a doctors license has been revoked or surrendered healthgrades displays all actions for doctors whose licenses have been revoked or surrenderedfor which states does healthgrades collect nondisciplinary board actionshealthgrades collects nondisciplinary board actions from all  us statesconditions treateddr bilenker does not have any conditions listed if you are dr bilenker and would like to add conditions you treat please update your free profileeducationmedical schooljohns hopkins univ sch of medgraduated in languages spokenenglishmemberships  professional affiliationsdr bilenker does not have any memberships or affiliations listed if you are dr bilenker and would like to add memberships or affiliations please update your free profilespecialtieshematologyhematology  oncologyprocedures performeddr bilenker does not have any procedures listed if you are dr bilenker and would like to add procedures you perform please update your free profile microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft joshua bilenker md  stamford ct  internist professionals doctorsttcqeayetrwczwezdueawsrsbdyr dentists podiatrists chiropractors optometrists facilities pharmacies nursing homes urgent care hospitals group practices patient education care guides well informed center corporate about us smartshopper vitalschoice advertise with us careers find location menu joshua bilenker md more information advertisement advertisement advertisement joshua bilenker is this you update your information here the vitals website is provided for your informational use only nothing contained or offered by on or through vitals should be construed as medical advice or relied upon for medical diagnosis or treatment vitals does not recommend or endorse any particular healthcare provider whose information or ratings appear on this website we encourage you to read our full terms of service advertisement inactive joshua bilenker md internal medicine stamford ct more information vitals cannot verify whether or not this professional is currently practicing we recommend that you attempt to contact the provider to verify their status please email us at supportvitalscom if you have any additional information summary locations  directions insurances credentials about joshua bilenker md is a doctor primarily located in stamford ct he has  years of experience his specialties include internal medicine and medical oncology he speaks english  language find out the languages this doctor or staff may speak view all  education learn where this doctor attended medical school view all advertisement specialties  expertisejoshua bilenker has the following  area of expertise and  specialties  specialties for the best health care select a doctor who specializes in your medical condition view all  expertise see areas of expertise for treating specific conditions procedures and surgeries for this doctor view all advertisement health guides metastatic melanoma the facts about metastatic melanoma a serious skin cancer including signs symptoms  what happens to the body in each stage of cancer view care guide more health guides birth control lung cancer skin cancer type  diabetes breast cancer cancer chemotherapy copd flu locations  directions  fieldstone rd stamford ct  get directions nearby doctors joshua bilenker md is similar to these  doctors near stamford ct dr michael zucker stamford ct   years experience view profile dr vipulkumar bhalodiya stamford ct   years experience view profile dr vernetta gallop stamford ct   years experience view profile advertisement advertisement home  find an internist  ct  stamford internists  joshua bilenker md advertisement